Antwerp, Belgium - 9 August 2019

Rejuvenate Biomed - a biomedical company that researches the biology of aging and applies this knowledge to identify drugs that delay the aging process – today announces it has been awarded a €1,160,000 Research Grant by Flanders Innovation & Entrepreneurship (VLAIO). The grant will be used to gain new insights in the aging pathways –which will ultimately contribute to the clinical research and the exploitation of a first lead candidate.

Rejuvenate Biomed, founded in 2017, aims to become a frontrunner in healthy aging prescription products which positively impact the health span, i.e. the length of time that a person is healthy while age increases.